SciVision Biotech Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 100.37 million compared to TWD 111.23 million a year ago. Net income was TWD 26.97 million compared to TWD 24.64 million a year ago. Basic earnings per share from continuing operations was TWD 0.41 compared to TWD 0.37 a year ago. Diluted earnings per share from continuing operations was TWD 0.41 compared to TWD 0.37 a year ago.